| Megan Vandervort, | |
|
169 Riverside Dr, Binghamton, NY 13905-4246 | |
| (607) 798-5255 | |
| Not Available |
| Full Name | Megan Vandervort |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 169 Riverside Dr, Binghamton, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275170573 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Vandervort, 125 Gardner Rd, Vestal, NY 13850-5950 Ph: (607) 240-7010 | Megan Vandervort, 169 Riverside Dr, Binghamton, NY 13905-4246 Ph: (607) 798-5255 |
News Archive
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
David Morris of Alexandria, Virginia has a fascinating job that takes him all over the world. So when arthritis and unrelenting knee pain put a crimp in his active lifestyle, he thought it was time to consider knee replacement.
Millions of women around the world use the combined hormonal oral contraceptive pill whcih has been around the past six decades. The usual method advised is a 21 day cycle of the pill followed by a 7 day break when the woman bleeds.
Combination immunotherapy as second or third line treatment extends overall survival to at least 15 months in patients with pleural malignant mesothelioma, according to late-breaking results from the MAPS2 trial presented today at the ESMO 2017 Congress in Madrid.
Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development, according to a new report from Quintiles, titled An Integrated Approach to Biosimilar Development & Commercialization. In addition, the report states that successful biosimilar companies will be those who collapse their clinical, commercial, and regulatory thinking into a streamlined cohesive function as they proceed with developing biosimilars.
› Verified 1 days ago
Mrs. Catherine Elizabeth Malarkey, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 85 Tompkins St, Binghamton, NY 13903 Phone: 570-592-2254 | |
Lauren Kline, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1333 Front St, Binghamton, NY 13901 Phone: 607-648-4646 | |
Courtney Hand, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-798-5255 Fax: 607-798-5192 | |
Denise Romano, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-798-5195 Fax: 607-798-5192 | |
Mrs. Devon Birek-collins, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10-42 Mitchell Ave, Binghamton, NY 13903 Phone: 607-762-6033 | |
Dr. Kathryn Marie Darling, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-798-5111 | |
Katherine I Ford, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Pennsylvania Ave, Suite 100, Binghamton, NY 13903 Phone: 607-723-8135 Fax: 607-723-4202 |